Sanjeeb Mukherjee And Sushmi Dey

Stories by Sanjeeb Mukherjee And Sushmi Dey

Govt to review suspension of 3 drugs

Govt to review suspension of 3 drugs

Rediff.com   10 Jul 2013

Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com   6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

Finally, health ministry acts on Uttarakhand

Finally, health ministry acts on Uttarakhand

Rediff.com   26 Jun 2013

Fearing outbreak of epidemics, the ministry is sending a high level team to review the public health measures in the area

Saradha fallout: Govt puts curbs on new co-op societies

Saradha fallout: Govt puts curbs on new co-op societies

Rediff.com   25 Jun 2013

Reaction to surge in applications, seemingly to hide identity as chit funds.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com   24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com   23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

It could pour miseries AGAIN on Uttarakhand

It could pour miseries AGAIN on Uttarakhand

Rediff.com   22 Jun 2013

The flood-hit religious destinations of Kedarnath, Badrinath, Yamunotri and Gangotri, where rescue operations are underway, would again record heavy rains from Thursday, the India Meteorological Department said on Friday. It also predicted "rather heavy showers" in Hemkund Sahib, another religious destination hit by flash floods and heavy rains, from Wednesday.

BSNL, MTNL may get relief on one-time spectrum fee

BSNL, MTNL may get relief on one-time spectrum fee

Rediff.com   19 Jun 2013

To revive the two state-run telecom operators, Bharat Sanchar Nigam Limited (BSNL) and Mahanagar Telephone Nigam Ltd (MTNL), the government is likely to waive the one-time fee these telcos need to pay for retaining additional spectrum.

Prices of key drugs to be cut by up to half

Prices of key drugs to be cut by up to half

Rediff.com   17 Jun 2013

The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com   13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Food Bill on Cabinet agenda

Food Bill on Cabinet agenda

Rediff.com   12 Jun 2013

Might discuss Ordinance route tomorrow, note circulated among ministers listing discussion topics.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com   12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

Airlines under CCI scanner for cargo fuel surcharge

Airlines under CCI scanner for cargo fuel surcharge

Rediff.com   12 Jun 2013

The complaint was lodged by Mumbai-based Express Industry Council of India, which represented major express courier and cargo companies such as DTDC, Aramex India, Blue Dart, DHL Express, GATI and First Flight.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com   11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Drug shortage likely as chemists run on limited stock

Drug shortage likely as chemists run on limited stock

Rediff.com   8 Jun 2013

There may be shortage of drugs till pharmaceutical companies supply new batches with revised MRPs.

Apollo Pharmacy halts sale of Ranbaxy drugs

Apollo Pharmacy halts sale of Ranbaxy drugs

Rediff.com   7 Jun 2013

Apollo Pharmacy, the country's largest branded drug retail network with over 1,500 outlets, has temporarily suspended sale of medicines manufactured by Ranbaxy Laboratories. It has also stopped further procurement from the company for now.

Singapore could be possible site for Ranbaxy arbitration

Singapore could be possible site for Ranbaxy arbitration

Rediff.com   3 Jun 2013

The 2008 deal agreement contains provisions of arbitration to be held in that country.

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com   1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

Ranbaxy seeks to convince Jaslok, Medicity

Ranbaxy seeks to convince Jaslok, Medicity

Rediff.com   30 May 2013

The trouble-stricken company has sought appointment with at least two major hospitals -- Mumbai-based Jaslok and Gurgaon-based Medanta Medicity.

FinMin for ban on pyramid marketing schemes

FinMin for ban on pyramid marketing schemes

Rediff.com   30 May 2013

No clarity yet on whether multi-level structure would escape ban.